| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0096 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |